Clinical Education & Training

Training to improve HIV care

Since its launch in 2011, the BC Centre for Excellence in HIV/AIDS (BC-CfE)’s highly regarded Education and Training program has engaged over 13,500 participants in educational programs and events by the end of June 2018. Of those, over 11,000 participated lecture events, over 1,400 took online courses and over 580 attended clinical training programs. “The

Training to improve HIV care Read More »

China CDC and BC-CfE renewed partnership reaffirms commitment to fight HIV

China is facing an HIV epidemic that is on the scale of its population of approximately 1.4 billion. The BC-CfE is providing valuable insights on successful tactics, programs and strategies implemented in British Columbia to curb HIV. Namely, the BC-CfE’s Treatment as Prevention (TasP) strategy has transformed the province from the one with the highest

China CDC and BC-CfE renewed partnership reaffirms commitment to fight HIV Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below